Trial intelligence / Profile preview

REPEAT: Single vs Repeated Bone Marrow Cells in Heart Failure

NCT01693042Phase 3Unknown

Sponsor
Universitätsklinikum Frankfurt
Start
Nov 2013
Primary completion
Nov 2022
Countries
1
01

Overview

A Phase 3 trial of autologous bone marrow-derived mononuclear cell in heart failure (HF), sponsored by Universitätsklinikum Frankfurt. Status: unknown.

02

Drugs

autologous bone marrow-derived mononuclear cell
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT01693042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01693042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call